Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Real-world Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Comparison With Other Regimens in People With HIV Starting Therapy With AIDS-Defining Conditions: Results From the CoRIS Cohort—The ACTUAS II Study, Clinical Infectious Diseases, March 2025, Oxford University Press (OUP),
DOI: 10.1093/cid/ciaf162.
You can read the full text:

Read

Contributors

The following have contributed to this page